Skip to main content

Premature clinical trials at UCLA

1 research study open to eligible people

Showing trials for
  • Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants

    open to all eligible people

    A comprehensive analysis of the impact of exogenous enteral DHA and ARA supplementation on lipid metabolism including the production of downstream derived mediators and how this impacts important biological pathways such as metabolism, inflammation, and organogenic factors.

    Los Angeles, California and other locations

Our lead scientists for Premature research studies include .

Last updated: